Novo Nordisk stock rises after Wegovy recommended by UK’s drug price regulator

Novo Nordisk rose as much as 4% after England’s drug price watchdog recommended the use of its best-selling drug Wegovy to prevent heart attacks and strokes, marking the first GLP-1…